Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.64 |
| ▸ | CASP1 | P29466 | 1/20 | 0.64 |
| ▸ | MPI | P34949 | 1/20 | 0.64 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.64 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | UBE2N | P61088 | 3/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.51 |
| ▸ | HEXA | P06865 | 2/20 | 0.49 |
| ▸ | HEXB | P07686 | 2/20 | 0.49 |
| ▸ | HTR1A | P08908 | 1/20 | 0.48 |
| ▸ | DRD2 | P14416 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7120133 | 0.84 | HPGD (0.60) | ALDH1A1HPGDCASP1MPICACNA1B | |
| SCHEMBL9290310 | 0.82 | ALDH1A1 (0.45) | ALDH1A1HPGDCASP1MPICACNA1B | |
| SCHEMBL7129147 | 0.82 | HPGD (0.57) | ALDH1A1HPGDCASP1MPICACNA1B | |
| SCHEMBL12561283 | 0.82 | HPGD (0.43) | ALDH1A1HPGDCASP1MPICACNA1B | |
| SCHEMBL9290314 | 0.81 | ALDH1A1 (0.44) | ALDH1A1HPGDCASP1MPICACNA1B | |
| SCHEMBL9290305 | 0.81 | HPGD (0.43) | ALDH1A1HPGDCASP1MPICACNA1B | |
| SCHEMBL6270684 | 0.78 | ALDH1A1 (1.00) | ALDH1A1HPGDCASP1MPICACNA1B | |
| SCHEMBL29437299 | 0.78 | ALDH1A1 (1.00) | ALDH1A1HPGDCASP1MPICACNA1B | |
| SCHEMBL9720971 | 0.78 | HPGD (0.70) | ALDH1A1HPGDCASP1MPICACNA1B | |
| SCHEMBL9290317 | 0.78 | CYP1B1 (0.56) | ALDH1A1LMNAKDM4EPOLBCYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9475991-B2 | Polymerizable liquid crystal composition, polarized light-emitting coating material, novel naphtholactam derivative novel coumarin derivative, novel nile red derivative, and novel anthracene derivative | ADEKA CORPORATION (JP) | 2016-10-25 | — | — | US | disclosed |
| US-9475991-B2 | Polymerizable liquid crystal composition, polarized light-emitting coating material, novel naphtholactam derivative novel coumarin derivative, novel nile red derivative, and novel anthracene derivative | ADEKA CORPORATION (JP) | 2016-10-25 | — | — | US | disclosed |
| US-20130334461-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLARIZED LIGHT-EMITTING COATING MATERIAL, NOVEL NAPHTHOLACTAM DERIVATIVE NOVEL COUMARIN DERIVATIVE, NOVEL NILE RED DERIVATIVE, AND NOVEL ANTHRACENE DERIVATIVE | ADEKA CORPORATION (JP) | 2013-12-19 | — | — | US | disclosed |
| US-20130334461-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLARIZED LIGHT-EMITTING COATING MATERIAL, NOVEL NAPHTHOLACTAM DERIVATIVE NOVEL COUMARIN DERIVATIVE, NOVEL NILE RED DERIVATIVE, AND NOVEL ANTHRACENE DERIVATIVE | ADEKA CORPORATION (JP) | 2013-12-19 | — | — | US | disclosed |
| US-8350054-B2 | Optical filter | ADEKA CORPORATION (JP) | 2013-01-08 | — | — | US | disclosed |
| US-8350054-B2 | Optical filter | ADEKA CORPORATION (JP) | 2013-01-08 | — | — | US | disclosed |
| EP-2458941-A1 | OPTICAL FILTER | Adeka Corporation (JP) | 2012-05-30 | — | — | EP | disclosed |
| US-20110152538-A1 | OPTICAL FILTER | ADEKA CORPORATION (JP) | 2011-06-23 | — | — | US | disclosed |
| US-20110152538-A1 | OPTICAL FILTER | ADEKA CORPORATION (JP) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152538-A1 | OPTICAL FILTER | C1R, CBR3, CBR1 | ALDH1A1 776/4885HPGD 1268/4885CASP1 3160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.